Patients with serious mental illness are presumed to be at high risk for poor adherence to HIV antiretrovirals; yet, there are no published studies of adherence to HIV medications in this population to substantiate this assumption. Methods: To assess the rates and correlates of adherence to HIV antiretrovirals in a sample of patients with serious mental illness, we conducted a study in which antiretroviral adherence was measured with electronic monitoring caps over a two-week observation period. Results: Forty-seven participants enrolled in the study. Psychiatric diagnoses included schizophrenia (n =12), schizoaffective disorder (n = 5), bipolar depression (n = 24), and major depression with psychotic features (n = 6). Mean age was 41, 79 percent were male, 23 percent did not complete high school, most were Caucasian (49 percent) or African American (43 percent), 25 percent were employed, 24 percent had temporary/unstable housing (including five participants who were homeless), and 50 percent had a history of intravenous drug use (IVDU). Mean CD4 count was 621 (SD = 335) and average viral load log was 2.7 (36 percent had an undetectable viral load). Average electronic monitored antiretroviral adherence was 66 percent (SD = 34), with 40 percent of the sample demonstrating at least 90 percent adherence. Lower adherence was significantly associated (p < .05) with higher viral load, history of IVDU, having missed recent clinic appointments, lower satisfaction with medical care and the relationship with one's doctor, greater perceived interference in one's life caused by treatment side effects, and alcohol and marijuana use. Conclusions: These findings suggest that as a group, persons with serious mental illness achieve an adherence level that is relatively low and similar to what other studies have found in groups suspected to be at high risk for poor adherence (active drug users, marginally housed), but the results also confirm that a large subgroup of this population are indeed able to adhere very well to antiretroviral regimens.
multidisciplinary team in the implementation and evaluation of this project will lead to the development of additional interventions to support the adherence of this clinic's diverse population.
Issues: Adherence support is as important among the HIVpositive homeless as among housed populations, yet the essential components of an adherence program among the HIV-positive urban poor are not established. Description: To assist homeless HIV-positive people adhere to ARVs, the city of San Francisco (SF) opened Action Point (AP) in 1999. AP is a street-based, drop-in program, centrally located in an area with high rates of illicit drug activity and homelessness. On-site staff includes nurses (RNs), social workers (SWs), a program assistant, and an acupuncturist. AP coordinates with a local pharmacy to dispense medications and minimize third-party billing problems. AP is unaffiliated with any one medical provider; clients receive primary care from more than 20 different medical clinics. Staff assists clients to obtain housing, promote harm reduction, and manage medication side effects. Staff advocates among providers for simple, effective medication regimens. A cash incentive engages new clients into AP. Lessons learned: An individualized adherence plan is the cornerstone of an adherence program among the urban poor. Staff must support clients through periods of hospitalization, incarceration, and drug use exacerbation to improve life expectancy and quality of life. Staff must work as a team to assist with complex medical and psychosocial needs. An endpoint to a client's cash incentive does not negatively impact their participation in AP. AP has enrolled over 150 HIV-positive urban poor and retained contact with almost 100 clients for more than a year. A mortality rate of 2 percent per year among AP clients is one-fourth the mortality rate of a representative sample of HIV-positive urban poor in SF.
-Assessing adherence readiness:
The role of the patient advocate Gerrity N. Garden State Infectious Disease Associates, NJ AETC, Voorhees, NJ This abstract will describe a program-based support service that assesses readiness of adherence. It will also describe the uniqueness of the patient advocate, methods used, and lessons learned. The program personnel are two FTE allied health personnel. They are the initial contact for newly positive clients. They are in a busy infectious disease practice in a suburban area covering five counties in South Jersey. The time period described is one year. The average caseload for the practice is 1,000 clients and has four attending physicians. The role was developed in response to low levels of adherence and increasing levels of drug resistance. Education was inconsistent and provided little opportunity for adequate questions. There was no specific point person. The role of patient advocate was initiated in June of 2001. They see all new referrals to the practice. Referrals can come from counseling and testing sites, correctional facilities, community-based case managers, and primary medical providers. Methods used include: telephone contact on a regular basis; trust building; provider-client matching; personal disclosure regarding affected as well as infected status and tolerance of alternative life styles. In the space of one year, approximately 400 new clients have been seen and followed closely for an average of four to six weeks. Patient advocates have found the following to be somewhat predictive in the success of adherence: Lifestyle: The more stable a person is in his lifestyle choices, the more chances he will be adherent. Self-Discipline: The more self-discipline a person exhibits, the more chance he will be adherent. Substance abuse: This raises a red flag and would not automatically preclude adherence but needs to be assessed as to active status and method of substance abuse. Interest expressed and questions asked: The more this occurs, the more likely a patient will be adherent. Support system: The more a person feels that they are loved and valued, the more adherent they are likely to be. Educational Level: This correlates with increased adherence. Body Language: This can offer cues to intent and whether someone comprehends the instruction and whether further clarification is needed. Transition to the adherence nurse is two-way and incorporates lessons learned from the initial adherence assessment.
-Treatment education and advocacy's effect on HIV viral load and CD4 count
Pearce D, Jenkins C, Resh B, Grimes W, Albritton T, Smith M. Comprehensive Health Center, San Diego, CA
Issues:
We proposed that those who demonstrated more empowerment while enrolled in a TEA program would have better self-reported adherence, HIV RNA (VL), and CD4s after six and 12 months than those who demonstrated less empowerment, or unenrolled controls. Description: From our urban community clinic, serving mainly indigent and people of color, 14 charts were selected for retrospective review from September, 1998 to February, 2002 for treatment-naive patients entering the TEA program. Sixteen naive control charts were selected from the same date range batches. CD4 and VL nearest the treatment baseline, six months and 12 months were recorded. Doses missed in the last month were recorded at each visit. TEA enrollees' behaviors at three months manifesting empowerment level were scored; the more active the behavior and the more behaviors, the higher the score. Lessons learned: There were no significant demographic differences, nor in self-reported missed doses at six or 12 months (sixth month: TEAs missed an average of 0.6 doses, controls 2.75; twelfth month: 0.5, 0.5), nor a significant correlation between self-reported adherence and level of empowerment. The TEA patients at baseline had a slightly higher logVL of 5.2 versus 4.7 (p=.02). At six months, the logVL drop was -3.1 in the TEAs, controls -2.2 (p=.05). The more empowered the TEAs were, the better their VLs trended, at six (p=0.09) and 12 (p=0.14) months, and the better the CD4s were (p =0.03, 0.04). There was no significant correlation between empowerment level and VL drops. Recommendations: A larger, randomized study is needed to better define the value of a standardized TEA.
-Politicizing adherence: The role of Ryan White Planning Council in improving adherence
Brennan C, Rose J. New Orleans Regional AIDS Planning Council, New Orleans, LA
The 2001 audit of the primary care services funded through Ryan White Title I in the New Orleans's EMA revealed that of the 465 charts reviewed, 26 percent had no documentation of an adherence plan. Recognizing that approximately 30 percent of HIV-infected individuals who are on HAART are not adherent to their therapy, the question was raised if the lack of documentation of an adherence plan by the primary care provider, which presumes a lack of implementation, may be contributing to nonadherence. In an attempt to address this potential cause of nonadherence, The New Orleans Regional AIDS Planning Council (NORAPC) has developed policies, in the structure of Standards of Care, to be implemented by those funded to provide primary care, case management, and medication services. The standards/policies were developed by the Primary Care Committee of NORAPC with input from case managers, primary care providers, health educators, pharmacists, and consumers. The standards require the implementation of certain services, which are directed to both staff and the agencies' consumers, and are intended to increase adherence to both HAART, as well as other medical interventions. Monitoring by the EMA's fiduciary agency will take place to assure all funded agencies within these three service categories meet these standards as a stipulation of their contracts and continuing funding. A second Primary Care Audit is planned in 2003 to evaluate the effect that these standards/policies have had on adherence and overall consumer well being.
-Facilitators and barriers to HIV medication adherence: Perspectives of clients and providers
Wenger L, Ciccarone D, Riess T, Edlin B. University of California San Francisco, San Francisco, CA Background: We present selected findings from an ongoing HRSA-funded evaluation of Action Point (AP), an innovative community-based structural intervention providing medication adherence support to the HIV-positive urban poor in San Francisco. Adherence support includes on-site medication distribution, nursing care, case management, and a text pager reminder system. In this paper, we describe facilitators of and barriers to program participation and medication adherence from the perspectives of AP clients and providers. Methods: Qualitative in-depth interviews with clients (n=19) and providers (n=9) were conducted, transcribed, and coded using Glaser and Strauss's constant comparative analysis method. Codes utilized in this analysis include: barriers and facilitators of participation and adherence, medication experiences, substance use, program changes, health status, and the impact of AP on clients' lives. Results: Experiences with side effects, number of pills prescribed, marginal housing status, mental health problems, and alcohol/drug use affected participants' ability to adhere to their medications. The use of medi-sets and text pagers and on-site medication distribution facilitated adherence. Substance use, staff turnover, and limited hours were described as obstacles to participation while positive relationships with staff, the drop-in nature of the program, and financial incentives were cited as facilitators of participation. Conclusion: Many clients who take antiretroviral medications experience difficulties that lead to poor adherence. However, the provision of adherence support services in a communitybased setting appears to improve clients' access to services and influences their ability to adhere to their antiretroviral medications. Further analyses will be presented examining the similarities and differences between client and provider perspectives on barriers and facilitators of program participation and medication adherence.
-Feasibility of utilizing support partners to enhance adherence: Experiences from Project HEART (Helping Enhance Adherence to Retroviral Therapies)
Davies G, Koenig K, Palmore M, Stratford D, Bush T, Malatino E, Todd-Turner M, Golde M, Ellerbrock T. Emory University, Atlanta, GA Issues: Social support enhances adherence, yet many HIV patients lack support, and little is known about utilizing patients' natural support systems. Description: HEART, an intervention that uses social support to improve adherence, was conducted at an urban clinic in Atlanta serving a predominantly minority, indigent population. Enrollment criteria required patients to identify a family member/friend willing to help with adherence and participate in team meetings. All support partners (SPs) attended an initial education session to view a tape on adherence. Some SPs and patients received enhanced intervention, attending additional meetings with education nurses to identify adherence barriers and solutions. SPs participated in this process and identified ways in which they could help. Lessons learned: Of 324 referred HIV patients, 300 (92.6 percent) were able to identify a SP. Of 112/117 enhanced intervention participants, 100 attended the first meeting (99 with their SP), 95 attended the second meeting (88 with SPs), and 83 attended the third meeting (52 with SPs). SP activities included reminding to take medications; picking up medications; cooking/shopping; providing bus fare or use of phone; and expressing concern. When asked what enhanced adherence, most reported, "my support partner" or an action by the SP. Ninety-three percent agreed that, "I feel this person understands me;" 95 percent agreed, "This person accepts me regardless of how well I control my HIV disease." Recommendations: Despite many social challenges, most patients had a SP. SPs provide many adherence-enhancing activities, are often accessible early in treatment, and should be considered for integration into adherence efforts.
-Using a treatment support group to enhance HAART adherence
Franklin L, Fine S. Community Health Network, Rochester, NY Issues: Social support and patient education have been associated with enhanced HAART adherence. A treatment education support group was formed to increase patient knowledge of treatment, expand support networks, and counter misinformation in the community. Description: An urban community-based HIV clinic offered a pilot treatment education support group to HIV-positive individuals. Recruitment was through physicians and community-based case managers. Ten HIV-positive persons of diverse ethnic, socioeconomic, educational backgrounds, and various reading levels participated. A physician and a treatment adherence counselor facilitated the weekly, one-hour group for nine months. Participants generated topics. Articles from scientific journals, patient magazines, and patient education materials were used for discussion. Participant experience, scientific research, and pop media declarations were discussed and analyzed. Lessons learned: All of the participants remarked on separate occasions how influential the group had been in meeting the demands of HAART. Since the inception of the group, one experienced his longest use of HAART therapy in his 15-year history. Another reported an improved relationship with his physician due to the support received. Participants developed solutions to adherence barriers for struggling members. On first and twelfth visit, surveys some showed an increase in vocabulary terms that they could "explain to a friend." Group members helped disseminate correct information into the community.
Recommendations:
This treatment education group pilot shows the impact such a group can have in supporting patient adherence to and satisfaction with treatment plan. The group met the needs of its small, diverse contingent. Recruitment efforts will now be multiplied through AIDS service organizations and the participants themselves. The group is considering multiple meetings a week. Issues: Between October 1999 and July 2002, a multifaceted approach was implemented to improve adherence to ART in patients in the HIV Program at the DVAMC. We assessed: 1) follow-up on clinic attendance; 2) readiness for ART;
-A randomized clinical trial (RCT) of peer support to promote antiretroviral therapy (ART) adherence
3) education about disease process and treatments available; 4) ART regimen difficulties; 5) social issues; 6) ethnic issues; 7) patient provider issues. Description: 1) Follow-up on patients not adherent with clinic appointments was made by phone or letter. Medication refills were discontinued if there was no response. 2) Patients being initiated on ART had a PharmD interaction and/or a complete assessment of readiness by their medical provider. This assessment included questions about compliance with other therapies, motivation, substance abuse, and patients' schedules. Patients were given picture charts, pillboxes, and other medication reminders. 3) Patients were given literature about their medications and were offered attendance at an HIV seminar. 4) Regimen difficulties were discussed with patients. Information about adherence elicited in a non-threatening manner was taught to staff and implemented. Patient preferences were taken into account as much as possible when deciding both initial and salvage regimens. 5) All patients with social issues met with the social worker to address these issues.
Patients with mental health or substance abuse issues were referred for treatment. ART was often deferred until these problems were stable. 6) An attempt was made to consider cultural/ethnic influences on adherence. 7) Providers were assigned to patients based on perceived patient/provider affinity and based on patient-expressed preference.
Conclusions:
A multifaceted approach to improving adherence in patients appears to be successful. In October 1999, 107/221 patients on ART had viral loads <500. In July 2002, 153/231 patients had viral loads <400. 
-

Issues:
The practice of storing and dispensing medications by HIV providers at an inner-city community health center was terminated by administrators in accordance with clinical regulations. This practice promoted adherence, as many patients were unable to receive medications at home via mail due to confidentiality concerns, or were unwilling to present to their local pharmacy due to fear of discrimination related to their seropositivity. A unique collaboration between an HIV specialty pharmacy and an HIV comprehensive care program was developed in response to this presenting challenge. Description: All participants in this intervention were ethnic minorities, of which 75 percent reported undocumented immigration status. The imposed constraint of shared living situations, along with the fear of disclosure of their HIV status were the motivating factors for patient participation. To address these issues, pharmacy staff agreed to store and dispense all medications, deliver them twice weekly by courier service to the HIV program in a secure tote, and return the tote to the pharmacy at the end of the day. Medications in sealed packages were given to patients by the HIV providers. Lessons learned: The social implications contributing to nonadherence are paramount for patients who are unable to disclose their HIV status. Institutional restraints may hinder non-traditional approaches to adherence. Instrumental to the success of adherence strategies is the ability to provide alternative options for patients confronted with these barriers to access medications in a safe and supportive environment. Recommendations: Creative strategies are necessary to support patients facing real and/or perceived threats of disclosure issues, which may impact their ability to adhere to prescribed therapies. This model highlights the importance of the provider/pharmacist relationship in establishing a collaborative approach to addressing barriers to adherence.
-Effect of an adherence program on HIV viral load in treatment experienced patients with a history of substance abuse and/or mental health illness: 36-week data
Battaglioli-DeNero A, Gallucci A, Stellrecht K, Piliero P, Clifford G. Albany Medical College, Albany, NY Background: Increased understanding of HIV pathogenesis and viral dynamics has led researchers to conclude that near perfect adherence to antiretroviral (ARV) therapy is needed to suppress viral load (VL) and prevent the development of drug resistance. The Albany Treatment Adherence Program (ATAP) is a specialized program that assists HIV-positive patients with adherence to ARV. Methods: A retrospective case-control study was performed. Eighteen charts of patients enrolled in ATAP who had SA and/or MH issues and a baseline VL of >1,000 were reviewed. Viral load at the nine-month follow-up visit was used as the primary endpoint. In addition, for ATAP patients, the number of adherence interventions, defined as phone calls and medication counseling, were counted. The ATAP patients were matched to 18 patients attending the same clinic, but not enrolled in ATAP. General clinic visits were counted for this group. Results: In a group of patients at great risk for nonadherence, enrollment in an adherence program led to a statistically significant decrease in VL six months later, compared to the control group. However, there is concern about the increased VL levels in both groups at the 36-week period, suggesting that continued efforts are needed to maintain optimal adherence. The number of encounters with the medical system for the ATAP patients was nearly six-fold greater than the control group. Conclusion: Adherence interventions in patients taking ARV therapy with a history of SA and/or MH illness led to a larger reduction in VL compared to a similar group not receiving such interventions.
-Placebo practice trials: A tool to assess and improve adherence readiness
Wagner G, 1 Iguchi M, 1 Schneider S, 2 Scott JD, 3 Anderson D. 3 1 RAND, Santa Monica, CA, 2 CARE Clinic, St. Mary Medical Center, Long Beach, CA, 3 Jeffrey Goodman Clinic, LA Gay & Lesbian Community Center, Los Angeles, CA Background: With antiretroviral therapy increasingly seen as less urgent and often delayed until later stages of illness, providers are emphasizing the need for patients to be ready to adhere well prior to prescribing HAART. Unfortunately, providers are no better than chance at predicting a patient's adherence, and there are no established methods for accurately assessing a patient's adherence readiness.
Methods: This pilot study assessed the utility of a series of up to five one-week placebo practice trials accompanied by adherence counseling as a clinical tool to both assess and improve adherence readiness. Participants were not prescribed treatment until they demonstrated readiness, defined as 90+ percent adherence during a single practice trial. Electronic monitoring caps were used to measure adherence. Results: Twenty men enrolled in the study at two HIV outpatient clinics in southern California. Nine participants achieved 90+ percent adherence in the first practice trial, with an additional eight participants demonstrating readiness after two to four practice trials; two participants withdrew from the study because of intolerance of the restrictions related to the use of the caps, and one participant was removed from the study after no effort was given during two practice trials.
Of the 17 participants who completed the program and demonstrated adherence readiness, 15 started on an antiretroviral regimen and two decided to defer treatment indefinitely. Of the 15 who started therapy, 13 (87 percent) achieved 90+ percent adherence during the first month of antiretroviral therapy. The sample's mean adherence during the first four weeks of treatment was 93 percent (SD=13). Conclusions: These results suggest that once a patient is able to adhere well to a one-week practice trial they are likely to adhere equally well to HAART, and call for a larger controlled study to further assess the effectiveness of practice trials as a clinical tool for both assessing and improving adherence readiness. Policies for dispensing ART to inmates vary across state correctional systems, with some systems using directly observed therapy, and other systems allowing inmates to self-regulate their medication regimens. Methods: This cross-sectional study administered questionnaires in a structured interview format to assess medication adherence, medication side effects, depressive symptoms, adherence selfefficacy, and barriers to taking medications among HIV-positive inmates taking self-regulated antiretroviral medication in a statewide correctional system. Results: The 77 participants were predominantly African-American men (93 percent M, 7 percent F; 60 percent AA, 27 percent C, 8 percent H, 5 percent other ethnicity) with asymptomatic HIV infections (CD4 M=515, range 3-1,461). Participants had been incarcerated for six weeks to 22 years (M=3.5 years) and the mean expected release time was three years. Thirty-five percent of inmates skipped ART doses in the past three days, 74 percent skipped any doses in the past three months, and 27 percent skipped doses at least weekly in the past three months. Adherence was significantly associated with HIV viral load levels (p <.001). Inmates who frequently skipped doses reported significantly greater depressive symptoms (p <.01), more severe medication side effects (p <.05), and less self-efficacy for adhering to treatment (p <.05) than those reporting good adherence. Frequent barriers included confidentiality and safety concerns, limited social support, interference from prison rules, difficulty remembering medication names/purposes, having too many pills, and difficulty refilling medications.
-Rates and correlates of self-regulated antiretroviral adherence in a state correctional system
Conclusions:
Results suggest an urgent need to enhance inmate adherence with interventions addressing a wide range of environmental, individual, and regimen-related barriers.
Interventions that reduce depression, improve side effect management, build self-efficacy, and improve problem-solving skills are likely to improve adherence to HIV treatment in correctional settings. The adherence implications of prison medication-dispensing policies will also be discussed. Utilizing multiple strategies to implement such a plan that addresses: determining readiness of the client to adhere; developing individual adherence treatments/plan; providing adherence aides; providing client education; and providing ongoing support and follow-up will be discussed in depth. The first essential component of this statewide plan is to work with the three central disciplines necessary to promote healthy adherence that are HIV providers, case managers, and pharmacists. Lessons learned: One major barrier that has been identified is the disconnect between medical providers and the HIV client's respective case manager in developing and implementing adherence plans.
-Design and implementation of a statewide
Recommendations: Discuss strategies that will foster a collaborative relationship and dialogue between all members who provide HIV care/case management in adherence plans for the rural PLWH/A client.
-Confidentiality issues relating to adherence in rural areas
Stalions T, McClure B. Heartland CARES, Inc., Paducah, KY Issues: Among the many factors standing between HIV positives and successful adherence is confidentiality. This issue is especially significant in rural areas where clients still face tremendous fear of exclusion from their respective communities, as well as the local social structure in general. This anxiety often prevents HIV positives from seeking and/or being adherent to treatment. Description: This presentation will demonstrate the process individuals in rural areas go through to accept their positive status, learning to seek and maintain treatment regimens, and feeling comfortable that their confidentiality is protected, yet not a constant barrier to adherence. In clinical settings that provide a multidiscipline approach, issues of confidentiality are addressed through the patient education program. Through discussion groups, support group sessions, client advocates, self-management classes, and mental health counseling, clients learn to manage their confidentiality, reducing the effects of this obstacle to adherence. Lessons learned: Identify individual issues about confidentiality through personal interviews and discussion groups. Address issues through client advocates, support group settings, self-management classes, and mental health counseling. Monitor progress through appointment adherence and continued counseling. Recommendations: Heartland CARES, Inc., strongly encourages HIV/AIDS service organizations to properly address issues of confidentiality in rural areas through patient education programs early in new client enrollment to reduce the effects of this issue on adherence.
-Integrating services in rural areas for better adherence
Taber S, Wood K. Heartland CARES, Inc., Paducah, KY Issues: Adherence rates of 90 to 95 percent are necessary to help reduce the chances of developing drug resistance and possible mutations of the HIV virus. However, multiple factors are involved with obtaining and continuing adherence, such as housing and transportation issues, budgeting, mental health problems, substance abuse issues, as well as balancing emotional, spiritual, sexual, and intellectual wellbeing, compounded by the challenge of living in a rural area. Clinical settings that provide a multidiscipline approach while incorporating self-management skills empower the client to be an active participant in his/her HIV/AIDS care. By incorporating social services with medical care, the client has access to a variety of services that together lead toward adherence. Description: It is the intent of this presentation to identify components of the self-management program, the planned visit team, and the multidiscipline team, and how these three approaches work with the client to be a self-manager. The self-management program involves review of the literature, individual and group activities, structured classes, and assessment tools to determine how the program is working for the client. The planned visit team and the multidiscipline team involve weekly meetings to review and share information regarding the needs and progress of the client. Lessons learned: Identify multiple barriers to adherence. Identify adherence tools. Develop a mentoring program. Develop a multi-faceted adherence program. Identify necessary life skills that lead to self-management of HIV treatment. Integrate community services. Recommendations: Heartland Cares, Inc. recommends integration of medical, social services, and community services for clients by providing self-management classes, and creating a planned visit and a multi-discipline team.
-Trust building as a paradigm for optimal HIV care management
Ruge C, Rodriguez J, Ramin J. Community Medical Alliance, Inc., Boston, MA
The HIV care management model to be presented emphasizes and integrates trust building between the HIV-positive client and the healthcare team at all levels of care. Community Medical Alliance, Inc. is a Nurse Practitioner-based model of care for people with HIV/AIDS. It is a multi-site practice with a central office in Boston, Massachusetts, which provides fully capitated managed care for people with HIV/AIDS. Our healthcare teams include Nurse Practitioners, Nurses, Behavioral Health clinicians, Addictions Advocates/outreach workers, Healthcare Assistants, and other office-based ancillary staff. We work in collaboration with the client's Primary Care Provider to provide optimal care with an emphasis on delivering that care where the people are, often going off-site to the person's home or to the streets. The guiding principles of this model include: maximizing access to care and information; client advocacy; honest and consistent communication; integration of mental health and substance abuse services with primary care; holistic symptom/pain management; improving communication/feedback between all practitioners involved in the client's care; and respect and acknowledgement of client priorities and diversity. This model has clearly resulted in improved medical outcomes for many of the clients served. Improved adherence to HAART and OI prophylaxis is a critical element to this success. However, understanding that undetectable viral loads, rising CD4 counts, and a life free of serious disabilities are not attainable for all clients, the foundations of empathy and trust which we work to strengthen throughout our relationship with our clients becomes even more important. The bonds of relationship and trust that we have built with these clients allow them the opportunity to maintain their quality of life throughout the course of their illnesses and to have death with dignity.
-Implementation of an innovative pharmacist-based adherence program in a large inner-city outpatient clinic
Helene H. Center for HIV/AIDS Care & Research, Massachusetts College of Pharmacy, Boston, MA Poor adherence to antiretroviral therapy represents one of the primary reasons for failure to achieve maximum viral suppression in HIV-infected persons and is often associated with the presence of an active psychiatric illness. We developed an innovative and structured pharmacist-based adherence program to determine if individualized monitoring of adherence to antiretroviral therapy (ARVT) and to psychotropic therapy (PT), when appropriate, improve and sustain virologic suppression in HIV-infected persons.
Patients initiating or re-starting ARVT will be eligible for the adherence program. Those willing to participate in the program will sign a detailed program enrollment agreement. The program will consist of ten adherence clinic visits spread over a twelve-month period. The innovative aspects of the program are two-fold: 1) Provide patients with a structured adherence program integrating both HIV and mental health related issues. 2) Assess if the use of an online adherence summary report enhances clinicians' ability to address adherence issues with patients and impact patient care. A series of questionnaires will be administered at baseline, week 24, and week 48 to assess changes in patients' mental health status, quality of life, level of education on ARVT and PT. Individualized adherence summary reports will be generated by the pharmacist after each clinic visit and entered into the patient's computerized medical record accessible by all clinic providers. Change in adherence score and virologic parameters will be measured at baseline, week 24, and week 48. This innovative program should provide useful insights on successful adherence interventions in HIV-infected patients from a large inner-city outpatient clinic.
It should also provide useful information on clinicians' confidence in the use of an electronic adherence assessment tool and promote the use of pharmacist-based adherence programs.
-Pharmacist-managed integrated HIV adherence program: Description and assessment
Scott JD, 1,2 Mashburn M, 1 Bolan RK. 2 1 Western University of Health Sciences College of Pharmacy, Pomona, CA, 2 Jeffrey Goodman Special Care Clinic, LA Gay and Lesbian Center, Los Angeles, CA Issues: Nonadherence to HIV treatment has been well established as a cause of treatment failure and HIV resistance. While no patient has all possible causes for nonadherence, most will have at least one or two. A well-trained clinical pharmacist is an ideal person to counsel patients on adherence. In consultation with the medical provider they can help find the best regimen, address patient-specific barriers, and help fit the regimen into the patient's life. Description: The Jeffrey Goodman Special Care Clinic (JGC) is a non-profit HIV clinic with >2,000 HIV-positive patients. In January 2001, an integrated, clinical pharmacist-coordinated adherence program started serving patients at JGC. The primary goal of the Adherence Improvement Program (AIP) was to improve the overall healthcare of patients by helping them successfully take their prescribed medications. The AIP is a consult service (with referrals from physicians, NPs, RNs and RPHs), with some visits requested by patients. During each 45 to 60 minute appointment, the following issues are addressed: patient-specific barriers to adherence (and possible methods of overcoming these barriers); appropriateness of therapy (with recommendations for future therapy); potential for enrollment into research studies; and other relevant issues. To date, 187 patients have been seen by the AIP (57 naive, 115 experienced, 15 in adherence-related research projects). Medication changes were recommended for 36 patients (19 percent), and 41 (22 percent) were seen multiple times. When possible, visits are billed under a supervising physician.
Lessons learned: 1) The AIP has been widely accepted by the providers and patients. 2) All patients have different barriers to adherence and each patient must be assessed for their own barriers.
3) The AIP provides an excellent teaching environment for pharmacy students (21 students have rotated through to date).
Recommendations:
More statistics need to be collected to further evaluate the effectiveness of the AIP.
-Identifying the needs of clinical providers to support client adherence to antiretroviral therapy
Baker L, Waters M. NYS/DOH/AIDS Institute, New York, NY Issues: It has become a commonly accepted fact that a 95 percent adherence rate is necessary for Highly Active Antiretroviral Therapy (HAART) to be effective in the management of HIV. While much research is now being conducted by public and private organizations to determine patients' needs to maintain or increase adherence, there is an absence of research aimed at identifying the needs of the clinical providers in their efforts to support their patients' adherence to antiretroviral therapy. The main goal of our study was to identify the needs of community-based clinical facilities to support client adherence to HAART. Sub-goals for this study were to categorize patient population and patient size for each responding clinical facility, to obtain an estimated patient load for each clinician, and to find what, if any, adherence services are currently being offered by these clinical facilities. Description: Since this is not a topic that has been previously studied in depth, we decided to approach this subject using exploratory research. This form of research was used to enable us to clarify problems or obstacles commonly faced by community-based medical providers when assisting their HIV-positive patients in adhering to long-term antiretroviral therapy, and to provide a foundation for future research into the subject. An open-ended question format was selected so as not to prejudice or limit possible respondent answers with preformatted responses for them to choose. Our sample frame was 38 clinical facilities (excluding facilities involved with treatment adherence studies or receiving funding for adherence services), known by the AIDS Institute, who provide HIV care in the five boroughs of NYC and in Westchester County. Three surveys were sent to each facility: one for the administrative director, one for the medical director, and one for the nursing director. Our response rate was 42 percent, meaning at least one director from a facility responded. Lessons learned: Sixty-one and one-half percent of all respondents (clinicians, nurses, and administrators) stated adherence counselors were needed to help increase adherence to HAART. Fifty percent of administrators stated lack of staff was their facility's biggest obstacle in providing adherence services. Seventy-one percent of facilities surveyed offer adherence education for their clients, 36 percent offered case management, 38 percent offered some form of medication services. Common reasons cited for nonadherence included pill burden, medication side effects, and treatment fatigue.
Recommendations:
We consider this the first step into the analysis and resolution of a long overlooked obstacle. We need to equip and empower those who provide direct care to HIV-positive patients receiving antiretroviral therapy, so they may provide optimal adherence services to their patients. Finding ways to integrate the strategies of community-based clinics and of those responsible for their funding, using sound theories of quality management, should be the focus in assisting clinical facilities in their efforts to increase adherence to antiretroviral therapy.
-RIME/EARS: A client-centered model of adherence counseling
Mitchell C, Linsk N, Nowak E, Noel E. University of Illinois at Chicago, Chicago, IL Issues: While health providers are often aware of the negative consequences of nonadherence to antiretroviral therapies, specific assessment and intervention tools are needed to successfully help the person with HIV achieve consistent adherence. The "RIME/EARS" model of adherence counseling is a client-centered intervention adaptable to a variety of health settings which targets support to the level of need of the individual as it changes over the course of treatment. Description: RIME/EARS (Readiness, Initiation, Maintenance and Evaluation/Engage, Assess, Recommend, Support) is rooted in the stages of change framework and recognizes the support that a patient needs may vary depending on where the patient is on the medication regimen timeline (eg, just commencing, maintaining adherence, or re-initiating following a change in regimen). The RIME/EARS model helps the clinician to understand patients' changing needs through a readiness assessment and to target support accordingly. This model has been incorporated into a two-part training within an AIDS Education Center-a didactic skills-building session and a patient simulation training experience.
Lessons learned:
This RIME/EARS model has been the underlying foundation of adherence counseling educational programs provided by the Midwest AIDS Training and Education Center (MATEC) in Illinois. Feedback from patient simulators and from trainees indicates that the model is a comprehensive, patient-centered approach to adherence counseling that builds on patient strengths and promotes positive patient-provider collaboration.
Recommendations: MATEC has been relying on anecdotal provider self-report to assess the effectiveness of the RIME/EARS model. At this point, however, MATEC sees the need to conduct a more rigorous outcome evaluation with a particular focus on measuring changes in providers' practices and ultimately on patients' adherence behaviors.
-Toward optimal adherence: Concepts from the world of business
Willner K. University of Washington, Seattle, WA Issues: Pagers, pill boxes, educational "how to" sessions, dire warnings of drug resistance: Why do we still have an adherence problem? Experts in human motivation are found in the world of business/advertising, athletics, corporations, and the military. Survival in these fields depends on their leaders' abilities to understand and motivate human behavior NOW. This presentation acquaints career medical practitioners and health educators with motivational concepts used in the world of business that may help us motivate patients to adhere to medication regimens.
Excerpts: 1) Advertising researchers report that people have subconscious beliefs about the way the world works and how we should respond. For example, Americans subconsciously hate perfection (emotionally, we equate it with "dead-end") and love a crisis (brings us to life). In contrast, we in healthcare try to teach patients to adhere perfectly and live stable lives. 2) Athletes, who vividly imagine their moves and winning, before they go on the court, perform better than athletes who only discuss the plays. Current adherence preparation usually mimics the latter. 3) Sports psychologists and drill sergeants teach their athletes/recruits how to use their bodies (posture, breathing, gestures) to reach desired emotional states. This model has not been adopted in mental healthcare where it may be a useful adjunct in the treatment of demoralization, depression, anxiety, and chronic stress. 4) Successful leaders in all four fields motivate themselves, workers, or customers with "why." Current adherence counseling tends to focus on "how" or the medical care provider's "why." Recommendation: The author is a student of education and psychology with a 20-year background in marketing and business. In the past three years of work in HIV health education, the author has observed that successful models for motivating behavior change in the world of business are not widely employed in clinical settings. It is recommended that current clinical models for motivation be revised using successful business models, with a reasonable expectation that we will help our patients improve their medication adherence.
-Evaluating a clinical trial to administer directly observed therapy (DOT) with HIV antiretrovirals
Sanford-Colby S, Macalino G, Mitty J, Flanigan T. Brown University, the Miriam Hospital, Providence, RI
Issues:
The Miriam Hospital is enrolling HIV-infected patients with active substance use disorders in a clinical trial designed to compare Directly Observed Therapy (DOT) with once-a-day HAART therapy to the control arm that will self-administer once-a-day HAART therapy and receive standard of care treatment through their primary care provider. Goals of the intervention will be evaluated using a broad range of clinical, social, and psychosocial data elements. Description: Data will be collected from a variety of different sources. Blood samples will be collected at each assessment visit to evaluate clinical outcomes. Information on potential predictors of adherence will be obtained from a questionnaire and several standardized tools that are administered at threemonth intervals. At each assessment visit, groups of questions are asked relating to religion/faith, incarceration, healthcare utilization, concomitant medical conditions, social needs, relationships with healthcare providers, knowledge and attitudes toward HIV, quality of life measures, mental health, risk behaviors, symptoms, body image, social support, side effects, self-reported pharmacy utilization, and contact with other adherence interventions. Participants randomized to the DOT arm will be asked questions specifically related to their experiences in DOT. Objective data on pharmacy utilization will be collected from local pharmacies. Billing data and staff time logs will be utilized to evaluate costeffectiveness. Detailed data on outreach workers (OW) visits with DOT participants will be collected using a daily log.
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Lessons learned: The questionnaire and other data collection tools have been modified several times to capture information on potential adherence issues that could not have been foreseen prior to study initiation. Recommendations: Well-designed data collection tools are crucial, particularly when used in the field rather than in the controlled setting of an interview room. This project has targeted 30 patients already engaged in care through Health Bridge who are to be supported to 1) prepare to start ARV therapy; 2) sustain adherence; and 3) graduate from this intensive support. The DART project will be offered in the morning, five days a week, at a diner located near the hotel clients are living in. Five clients will meet with an outreach worker to take their medications and discuss issues related to adherence. At each session, adherence to doses the prior day (or weekend) will be assessed. Barriers to adherence and strategies to overcome them will be discussed. The project consists of five phases of increasing patient autonomy which clients progress through. Lessons learned: The logistics and feasibility of planning, implementing, and evaluating this program will be reported. An analysis of the daily topics discussed, and the assessment of patient adherence and biological outcomes will provide an in-depth understanding of the patients' perceptions of their barriers to adherence and of how hospital-based outreach programs can effectively work with patients and clinicians to overcome these barriers. Recommendations: 'Adjuvant' DOT is offered as an approach through which to understand and modulate adherence supports to meet the changing needs of individuals confronting the challenge of simultaneous adherence to risk behavior management, health maintenance, and disease management.
-From
-Challenges in the development of an HIV directly observed therapy (DOT) program
Mitty J, Macalino G, Mock M, MacLeod C, Sanford S, Flanigan T. The Miriam Hospital, Brown University Medical School, Brown University, Providence, RI Issues: HIV DOT may serve as a way to increase access and enhance adherence to antiretroviral therapy in certain populations.
We are currently enrolling participants in a randomized controlled trial, comparing DOT to standard of care (SOC) utilizing a oncedaily regimen for individuals with active substance abuse disorders. In the development of our trial, we continue to address the question of how to meet the individualized needs of this population, while at the same time, providing a standardized intervention. Description: Participants with active substance abuse disorders are randomized to DOT or SOC. For participants receiving DOT, a near peer outreach worker (ORW) meets with them seven out of seven days to observe the dose being taken. After three months, visits may be tapered based on an individual's readiness.
Lessons learned:
To date, we have enrolled 21 participants with 13 randomized to DOT and 8 to SOC. The time from screening to entry into the study takes an average of 14 days, and is an impediment for active substance abusers. For those individuals receiving DOT, three were receptive to DOT visits, but after one to two months started working, and wanted to taper visits. Two participants preferred taking their medications at bedtime, but were receptive to daily phone calls. Two participants decided to interrupt their medications, but anticipated restarting them and re-initiating DOT at that time. Two participants would not meet regularly with the ORW until they met with their primary care provider who emphasized the need for the intervention.
Recommendations: In the setting of HIV DOT, particularly with active substance abusers, interventions must incorporate a significant degree of flexibility to address the individual needs of this diverse patient population. In addition, primary care provider support may help individuals develop trust in the program.
-Cost-effectiveness evaluation of a directly observed therapy (DOT) program for HIV antiretroviral medications: Practical considerations
Macalino G, Sanford-Colby S, Mitty J, Flanigan T. The Miriam Hospital, Brown University, Providence, RI
Issues:
A cost-effectiveness evaluation has been designed within the setting of an NIH-funded clinical trial that compares DOT for HIV antiretroviral medications to standard of care among substance users. Practical considerations are discussed. Description: It is important to distinguish between researchdriven and actual intervention costs for the purposes of evaluating DOT cost-effectiveness. One advantage of collecting cost data as part of a research project is that financial and client records tend to be complete and detailed. While most of our evaluation and intervention staff tend to be different employees, staff time logs will assist in allocating time and effort spent on the actual intervention (eg, medical director, project director, project nurse, outreach workers). Staff interviews determine necessary tasks for the maintenance of the intervention (regardless of the evaluation), including outreach worker training, filling out outreach worker logs, etc. Direct costs (equipment, supplies, postage, phone use, advertising costs) and indirect costs (space, allocation of administrative staff, and resource use/other overhead expenses) can be divided by people and time spent on the intervention. Most of these expenses can be obtained from the hospital general ledger. Expenses incurred by participants will include time spent participating in DOT. Inpatient hospital expenses, as well as outpatient service costs, will be obtained from hospital billing downloads. Lessons learned: Cost data is often already being collected for other purposes and it is feasible to evaluate the cost effectiveness of an intervention in the context of a research study. It is essential to keep track of the complex components of an intervention, separate from evaluation. IRB approval from participants is necessary to obtain patient billing data. Recommendations: Adherence interventions should have a cost component to determine its effectiveness. This is feasible in most situations. Participants are admitted to a skilled nursing facility for four to six weeks where community volunteers, social workers, and medical staff supervise DOT, HIV education, and psychosocial support groups designed to address individual barriers to adherence. Adherence is assessed periodically after discharge by viral load PCR (VL) and patient/provider report. Results: Fifty-four START participants (mean age 30 years, 4 percent female) were followed for a mean of 24 months after discharge. Ninety-five percent had AIDS. Eighty-five percent were admitted from local hospitals following an Opportunistic Infection. Two participants died and 16 were lost to follow-up.
-Directly administered antiretroviral therapy improves rates of viral suppression compared to standard care and an intensive adherence intervention
Of the remaining 36 participants, 50 percent maintained adherence to ARV, as reported by both patient and provider and confirmed by suppressed VL. Eleven percent achieved sustained VL<50 copies and 89 percent maintained VL<1,000 copies. Of the 16 (34 percent) participants who did not sustain adherence, failure was attributed to multi-drug resistance to ARVs, relapse of substance abuse or psychiatric disease exacerbation. Adherence did not vary by race, age, gender, or risk group. Conclusions: START achieved sustained adherence in 26 out of 52 participants (50 percent) and viral suppression in 35 percent of previously nonadherent participants with advanced HIV disease. Short-term inpatient DOT interventions may facilitate long-term adherence and viral suppression in patients with refractory nonadherence. 
-Effects of the physical environment on the learning process related to medication adherence in HIV-positive patients
-Medication adherence in clients with mental health Issues: A community-based social work perspective
Hosler J, Botson J, Wukich N. San Francisco AIDS Foundation Action Point Center, San Francisco, CA
Adherence training with HIV-infected urban poor poses challenges for social workers (SW). Among these is working with clients who suffer from chronic mental illness. Mental health (MH) issues may exacerbate a client's ability to successfully adhere to complex HIV therapies. Action Point (AP) works closely with clients to address MH issues and provides one-to-one interventions to help clients better adhere. AP is a medication adherence program located in San Francisco's Tenderloin area, characterized by high crime rates, drug use, and homelessness. One role of the SW is to assess how a client's MH issues impact adherence. In collaboration with the client, the AP team coordinates, plans, and implements strategies for better adherence. The lack of predictability and severity of MH symptoms necessitates the need for a proactive relationship with clients and their community healthcare providers. Working with mentally ill clients requires true collaboration between AP staff and other providers. Taking the time to meet with a client's therapist, other case managers, or medical providers enhances knowledge about clients' MH issues as well as provides additional resources. These connections are essential in times of crisis or when the client requires a change in psychiatric medications. Another aspect, which is vital to working with clients, is the proactive role taken in their lives. This type of "assertive case management" helps clients, who may not otherwise seek MH services, feel more at ease entering and remaining in the system. A reluctant client may follow through with MH referrals if a SW or other advocate accompanies the client on their initial visit. Due to the complexity of working with dually diagnosed clients, caseloads should be small to allow for the SW to build strong relationships with clients and providers. AP will explore implementing adherence support groups to give clients the opportunity to share experiences and strategies to better adhere to medications. Conclusions: Results suggest that a successful intervention must target cognitive factors that affect self-efficacy and progression to action and maintenance stages of change to ensure long-term success. Motivational Enhancement Therapy (MET) is such an intervention, and we are currently piloting MET to reduce risk behaviors including adherence in HIVpositive youth.
-Psychological correlates and planned interventions for adherence to medications in HIV-positive youth
-Impact of housing on medication adherence among persons living with HIV/AIDS
Gray J. School of Nursing, University of Texas at Arlington, Arlington, TX
The purpose of this study was to describe self-reported adherence to antiretroviral medications over time and explore the impact of housing on adherence. The study was conducted in an infectious disease clinic in a county hospital system and in a residential shelter for the homeless. Residents at the shelter were reminded to pick up each dose of their medications, so it was anticipated that adherence rates would be higher for shelter participants than for clinic participants. After providing informed consent, each participant completed a pencil-paper packet of instruments (N=102). Approximately one to three months apart, the participants provided additional information about adherence at clinic visits or data collection times at the shelter. While 70 participants completed four or more packets, only 29 completed the study, providing data seven times. Attrition rates between the two sites were significantly different, with more of the shelter participants completing the study (Chi-square= 4.78, p = .03). The percentage of total participants who reported never missing medications or not missing in the last three months at study entry was 39.2 percent (n = 38). The difference in the percentage over time was non-significant (Time 2 = 48.8 percent, n = 41; Time 3 = 49.4 percent, n = 39; Time 4 = 52.1 percent, n = 37; Time 5 = 54.3 percent, n = 32; Time 6 = 56.6 percent, n = 26; Time 7 = 34.2 percent, n = 23). Because of the small sample size, participants were divided into high adherence and low adherence groups to compare adherence between the two sites. Chi-square analysis did not reveal any significant differences in self-reported adherence between participants at the sites. Further studies are needed to explore the pilltaking behaviors of shelter residents to determine why nonadherence was prevalent despite reminders and distribution of medications. Patients kept 76 percent of their scheduled weekly contacts with their case manager. Patients who have been in the intervention for at least three months (n = 15) achieved 64 percent of the goals established in their initial adherence plan. Patients who completed the six-month intervention (n = 7) met 96 percent of their adherence plan goals. Among patients with self-reported adherence data at three months of follow-up (n = 9), 89 percent reported taking 100 percent of their HAART medications in the last three days, compared to 78 percent of the patients who received no intervention (n = 9). All seven of the patients who have completed the intervention reported that: 1) the program helped them adhere to their HAART regimens; 2) the case manager helped them to manage their HIV disease; and 3) they would recommend the program to other people who are HIV positive. Recommendations: Preliminary findings suggest that the delivery of intensive case management to persons on HAART is well accepted by the patient and can identify and meet goals to overcome barriers to adherence and address other unmet needs that facilitate behavior change.
-Using an intensive case management model to overcome obstacles to HAART adherence
-Establishment of a social support network after HIV-positive diagnosis
Kelly A, Fine S, Franklin L. Community Health Network, Rochester, NY
Background: Establishing a social support network is correlated with enhanced adherence to HAART. However, little is known about when and whom patients disclose their HIV status to after diagnosis. This chronology is crucial because it forms the basis of a social support system that will help patients meet the demands of meticulous adherence. We investigated the chronology of patients' disclosure of HIV status and level of support received after disclosure. Methods: Chart reviews and interviews with a survey were conducted with 30 patients from a community HIV clinic. Patients were questioned regarding: perceived social support network; to whom/when they disclosed HIV status and responses received; and how supports enhanced adherence. Results: Participants were 67 percent male, 53 percent white, 37 percent black, and 10 percent Hispanic. Risk factors included homosexual sex (40 percent), heterosexual sex (37 percent), and IVDU (17 percent). Mean age was 41. Average time passed since positive diagnosis was 8.4 years. While 83 percent disclosed status to someone within one month, 17 percent did not. Many (67 percent) told either a family member or significant other first. The majority (97 percent) received support at disclosure. Those who delayed often told a service provider or casual acquaintance, someone less able to provide support. Conclusions: The sample suggests that most patients confide in family or significant other within one month of diagnosis and receive support upon disclosure. Those who have not disclosed in first month, wait long periods of time and tell peripheral relationships less able to provide the daily support needed to adhere to HAART. Providers might identify those at risk for weak support systems and decreased adherence by inquiring one month after diagnosis whether a patient has disclosed. Intervention may be considered for those who have delayed disclosure.
-Utilization of a medication history form to assess patient adherence
Bishop MR, Adams TW, Huang AK. WINGS Clinic, University of Louisville Healthcare, University of Louisville School of Medicine, Louisville, KY A concise medication history form was developed to assess the needs and collaborative services that the HIV/AIDS population requires. It was designed to systematically obtain pertinent information and is administered by the pharmacist during each new patient visit and is reviewed quarterly. Each section reveals the potential for referral to maximize the interdisciplinary approach of our clinic. WINGS, a Ryan White III funded clinic, is demographically 43 percent African American, 27 percent female, and 30 percent ADAP eligible. The team members of WINGS include: physicians, midlevels, a pharmacist, a social worker, nutritionist, substance abuse counselors, psychiatrist, legal aid, and dental services. Patients referred to the pharmacist are either newly diagnosed, starting antiretroviral therapy, changing therapy, or having adherence problems. The interview provides insights to the patient's lifestyle, behavioral risks, nutritional status, and financial situation. It also explores the patient's knowledge of HIV/AIDS and provides the opportunity for education, regarding dosing regimens, drug interactions, side effect management, and the necessity of 95 percent adherence. This educational process is used to select the best regimen to fit the patient's lifestyle with the minimum of side effects. This form has served to maximize the interdisciplinary services of WINGS enhancing patient care. Our next step is to demonstrate the cost effectiveness of improving adherence through this collaborative holistic approach to HIV/AIDS.
-A birthday card program as a patient-centered adherence tool
Hewitt R, Cruz R, Chase M, Greenway D, Lewis D, Walsh K. University at Buffalo and Erie County Medical Center, Buffalo, NY Issues: Many factors affect HIV-positive patients' adherence to HAART. Among them is self-esteem and rapport with the provider. A multidisciplinary committee designed and implemented a birthday card program to help address both of these factors. Description: Our birthday card program began in March 2001. We designed a contest to create cards that fit a card size envelope and said "Happy Birthday" without reference to age, sex, gender, or race. Contest rules were mailed to area art teachers. Cash prizes were awarded to winning schools and students. Ten schools entered the contest. Over 500 cards were received, created by children from grades one to eight. Teachers nominated the top three cards from their school. A panel of HIV-positive people judged the entries. Winning cards were reproduced for future distribution. All cards received were mailed to patients. Clinic staff visited winning schools, and presented teachers and students with checks and certificates. We began mailing about 80 cards per month (for patients whose birthdays fall within that month) in September 2001, using a list that is verified by clinic staff for accuracy and relevance. Cards returned for address corrections are re-sent. One administrative staff person coordinates the program. The program was funded by a US$5,000 grant from Roche Laboratories. Lessons learned: The goal of improving rapport appears to be working. Patients often call the clinic when they receive the card to say thank you. One patient told us he keeps the card on his mantle since it is the first birthday card he has received in 30 years. Results from a formal survey of our patients about the card program will be presented at the conference. Recommendations: A birthday card program is a simple and inexpensive way to improve rapport with the clinical program by reaffirming patients' humanity. Whether the cards also help improve self-esteem remains to be determined. It is hoped that improved rapport will lead to improved adherence for patients receiving HAART. We have developed an assessment-based intervention to improve adherence. With the help of a questionnaire, patients identify their adherence barriers, and a clinical pharmacist follows a set of predetermined guidelines to help the patient develop an adherence improvement plan to reduce or remove these barriers. One hundred HIV patients on HAART are randomized either to continue standard care alone, or to receive standard care plus the intervention. At baseline, two and 12 weeks, all patients estimate their HAART adherence, and patients in the intervention group estimate the extent to which the previously identified barriers have affected their adherence. Patients who had the intervention also report their satisfaction with it and how well they followed the adherence improvement plan. Results: Analysis of the 77 patients enrolled to date suggests a statistically significant and clinically relevant increase in adherence at the two-week follow-up. Twelve-week data is pending. Final analysis will include: baseline reasons for missed doses; group differences at follow-ups; number and frequency of adherence barriers; patient satisfaction with the intervention; patient follow-through with the adherence improvement plan; and viral load and CD4 counts. Conclusions: Lessons learned in developing and implementing the intervention will be presented. Recommendations will be discussed. 
-Increasing adherence to HAART with a brief assessmentbased intervention: A preliminary evaluation
-Does closely supervised adherence intervention for six months improve virologic outcomes among urban indigent women?
Conclusions:
Intensive ACT intervention resulted in successful short-term virologic outcomes in these hard-toreach patients. Long-term impact of the intervention needs to be studied. Issues: Would it not be better to shift the focus of discussion from "adherence to medication" to "adherence to a clinicianpatient relationship?" Can it be demonstrated that this "team" approach is effective, and supports and maximizes clinical and functional outcomes? Description: A systemic, low-cost, "value-add on" approach to adherence developed by an ID specialist serving 500 patients/ families located within a major teaching hospital in BA is presented. Working in tandem with a psychologist, case manager, and peers, the team has crafted a program through which education, counseling and a net of logistical and psychological supports are offered in this resource-poor city enduring major crisis. Lessons learned: Return on time invested: Is time saved and medication resistance avoided later; personalized, progressive teaching prepares patient to respond to problems and barriers in a very timely "skillful" manner; and-most importantthe clinician must become as "adherent" to the relationship as is the patient, placing on each an equal responsibility. Teamwork: The team must consist of patient and supporters (family, friends, partner) and the clinical group (clinician, psychologist or group therapist, office support). Access: The patient and supporters must have easy access to the clinical team; the clinical team must have access to sufficient lifestyle information; all education/teaching must be individualized to "meet patients where they are at" (comfort, understanding, motivation, skills). The responsibility of choice: Patient is informed/educated at all clinical and therapeutic decision points; the patient is encouraged to identify, assess, and report problems freely.
-Elements for success: A behavioral change and harm reduction model for adherence to medication and care regimes in Buenos Aires, Argentina
Recommendations:
The service-driven model is being further formalized, together with US collaborators, through a Mount Sinai/Argentina NIH/Fogarty AIDS International Training Research Program to support its evaluation, codification, and replication/modification in other settings.
-Factors perceived to influence antiretroviral therapy adherence by patients with nondetectable levels of plasma HIV
Wolbert J. Bellevue Hospital Satellite Clinic, New York, NY Strict adherence to antiretroviral medication regimens is considered critical in reducing measurable HIV in the blood. Studies have shown that adherence rates of 95 percent or greater are needed to suppress viral replication and maintain the efficacy of a given regimen. Nonadherence to antiretroviral therapy (ART) is a major cause for failure of regimens and the consequent development of drug-resistant virus. Multiple studies exist that explore adherence to ART in relation to characteristics of the therapy and/or characteristics of the patient. These studies often examine patients with and without measurable HIV in their blood. This study involves only those patients who have had nondetectable viral loads for a year or more, which is considered a marker for excellent adherence.
Participants are asked to complete a survey designed to elicit their perceptions of what factors had the greatest impact on fostering adherence to their medications. The factors may be related to the regimen itself (eg, pill burden), the patient (eg, belief that the medications will work), or their provider/heathcare team (eg, adequate education about the medications). Participants are also asked to suggest ways that, in retrospect, could have facilitated their adherence. Data is being collected presently. The sample size is expected to be at least 40 patients.
-Evaluation of an adherence program among heavily pre-treated patients referred for known or perceived risk of nonadherence to antiretroviral therapy (ART)
Celano S, Keruly J, Moore R. Johns Hopkins University School of Medicine, Baltimore, MD Background: It is known that >90 percent adherence to highly active antiretroviral therapy (HAART) is needed to achieve durable HIV-viral load (VL) suppression. Data from clinical cohorts show that adherence to HAART rarely achieves this level, and strategies for adherence support are needed to approach this goal. A 12-month adherence program (LINK) was begun in a HIV specialty practice to provide nurse education, case management, group counseling, and peer support. We wished to examine the relationship between LINK and clinical outcomes of initiation of HAART, HIV-1 VL changes, and CD4 count. Results: Among LINK enrollees, 56 percent are male, 95 percent African American, with a median age of 46 years. HIV risk behavior was 40 percent IDU; 9 percent MSM; 45 percent heterosexual; 6 percent other. Baseline CD4 count was 149 cells/mm 3 , and VL was 215,183 copies/ml (4.65 log 10 ). Eighty-seven percent had a prior history of ART. At BL, 107 (66 percent) were not on ART. By six months of FU, 87 of 107 (81 percent) initiated HAART. At six months, 111 of 163 (68 percent) remained on HAART, 37 percent had VL <400 copies, 72 percent had decrease in VL, and 66 percent had an increase in CD4. Overall, VL decrease from BL was -1.17 log 10 (SD 1.66), and CD4 change from BL was 39 cells/mm 3 (SD 118). Conclusions: Preliminary data suggest that in a heavily pretreated group of patients, LINK supports initiation of treatment and achievement of immunologic and virologic improvements.
-MASS Memorial HIV medication adherence program
Cullen E, Mangini L, Cheeseman S, Rulnick S, Pottage M, O'Reilly L, Jaffarian C, Savasta AM. UMASS Memorial Health Care, Worcester, MA Medication adherence has emerged as the single most important factor in achieving viral suppression (Reiter, et al, 2000) . The ability of patient adherence is essential for successful treatment. Nonadherence to Highly Active Antiretroviral Therapy (HAART) leads to treatment failure and transmissible drug-resistant viral strains. Resistance may limit the number of effective regimens for treatment (Yamashita et al, 2001) . Studies have shown that 95 of percent doses are necessary for optimal viral suppression, otherwise virologic failure is evident (Paterson, et al, 2000) . An adherence program was developed to improve medication adherence, help patients engage in self-care, and improve overall patient outcome. The program is based on a multidisciplinary approach focused on assessments (Learning Style Inventory) of the patient's individualized learning style. A plan is tailored to the individual's specific learning needs based on visual, auditory, or tactile styles of learning. Specific tools are utilized to maximize each patient's ability to successfully achieve an improved level of medication adherence. Visual learners utilize pictures/charts/ handouts and videotapes; audio learners find cassette tapes of instructional patient/provider visits, programmable alarms, and pillboxes helpful, while tactile learners benefit from note taking and writing medication schedules. Intensive patient/ support-system education is based on initial assessment and follow-up is ongoing. Considerations for inclusion of multicultural and socioeconomic issues were made to target the diverse patient population. The program was initiated in January 2002, and presently consists of 28 patients. Target groups consist of naive patients, regimen change and reinforcement of present HAART. Data is inconclusive at this time. Further recommendations include analysis of data, referral protocol and target interventions for primary care settings. 
-Utilization and outcomes of an adherence program in a rural/suburban community HIV clinic
-Es por la vida: A program to enhance treatment adherence in low-income Latino HIV-infected men and women
van Servellen G, Garcia L, Herrera G. UCLA, Los Angeles, CA Issues: Achieving near perfect adherence to combination antiretroviral therapy can be difficult under any circumstance. For impoverished racial/ethnic minority groups, the risk of less-than-perfect adherence may be a result of a wide range of factors. Within group vulnerability is evidenced in individuals who present with delayed diagnoses, are less likely to comprehend disease complexities, and more likely to mistrust or misunderstand their treatment regimen. While these difficulties can be explained in part by individual factors, other system related factors (eg, the availability of support services, impact existing treatment adherence initiatives. Description: In collaboration with Alta Med Health Services, HIV Division, we designed and implemented a randomized trial to test the acceptability and effectiveness of a combined instructional support, and tailored nurse-case managed follow-up program for under-served populations of Latino men and women. Spanish-speaking patients, 18 years and older, on combination therapy for at least three months, with less than HS education, detectable viral loads, and reported adherence difficulties, were recruited. Lessons learned: The presentation will address the following Lessons learned: 1) Programs should be designed to reflect key cultural values. 2) Compatibility of research and service goals must be continuously articulated. 3) Assumptions about the role of acculturation and literacy should be challenged. 4) A focus upon everyday life and enhancement of quality of life is needed. 5) Significant barriers include the integration of support services. Recommendations: Adherence enhancement programs targeting the individual and system of care have the potential to improve treatment adherence and reduce HIV risk behaviors. This dual approach is particularly important in communities where HIV infection rates are increasing and supportive care services are limited. presented four times to small groups of four or five students. There were 17 students who attended the University. Out of the 17 students there were nine Caucasian, six African American, one Hispanic, and one American Indian. Out of the 17 patients, 10 lived alone, six lived with family, one lived in a shelter, and one was homeless.
-HIV seminar series and impact on HIV viral loads and CD4 cell counts in HIV-infected patients
Lessons learned: Preliminary HIVU may have had a positive impact on adherence. We observed a trend towards improved HIV VLs and CD4s. Two patients who were assessed to be nonadherent before appear to remain nonadherent (NA). Pre-HIVU HIV RNA (copies/ml) >50-6; 50-400-3; >400-4; >400 and NA-2; Off Treatment-2; Median CD4-339. Post-HIVU RNA (copies/ml; last visit-mean 7.1 weeks; range one week-12 weeks post-HIVU) >50-9; 50-400-1; >400-3; >400 and NA-2; Off Treatment-2; Median CD4-352. Patients who attended identified the four top barriers to adherence as 1) intolerance, 2) travel, 3) falling asleep, 4) forgetting.
Recommendations: HIVU offers patients with adherence issues and those considering initiating ART information about HIV regimens and the importance of being adherent. Although preliminary results are encouraging, new approaches may be needed for highly nonadherent patients. 
-Enhancing adherence in HIV-positive patients through a multidisciplinary educational orientation
-Medication adherence in a Latino community health center: A bicultural multidisciplinary readiness model
Alvarez R, Spring R. Mission Neighborhood Health Center, San Francisco, CA Issues: HIV is unique among infectious diseases because of the duration of illness, the duration of therapy, and the inability to cure the patient. An asymptomatic young person may face a lifetime of multiple medications requiring near perfect adherence to prevent resistance. The ability of the patient to adhere to such a regimen is the subject of great research interest which to date shows high rates of nonadherence, high rates of resistance, and significant methodological challenges of measuring adherence. There is a dearth of research examining the culturallyspecific concerns of adherence in the Latino community. Description: Mission Neighborhood Health Center's Clinica Esperanza is the recipient of a Special Projects of National Significance (SPNS) grant through HRSA to evaluate its Medication Adherence Program (MAP) which emphasizes a multidisciplinary readiness program in a culturally competent clinical setting. A formal instrument is provided at baseline and at quarterly follow-ups. Lessons learned: 1) Cultural competence requires that what may be perceived as deficits in our patients may, in fact, be strengths. Fear of medications and skepticism about its value in healthier patients may serve as the basis of exploring community wisdom that has been validated by the multiple revisions of the treatment guidelines. 2) Successful adherence programs must have a strong readiness component to anticipate and respond to possible barriers before the initiation of therapy. It is essential that there is a strong relationship with the adherence support staff be they case manager, nurse, or physician.
3) Culturally competent adherence support in the Latino community must address variables such as language facility, immigration patterns, poverty, health beliefs, and degree of acculturation.
Recommendations: An appreciation of the complexities of adherence necessitates excellent communications between physicians and social workers, health educators, and other team members. Institutional supports must be provided to promote interdisciplinary collaboration. All disciplines must invest the time in learning the rudiments of ARV therapy and management of side effects, and physicians must solicit the input of their colleagues regarding matters of readiness and regimen selection.
-Can peer support enhance antiretroviral adherence in the Bronx?
Simoni J, Lockhart D, Frick P. University of Washington, Seattle, WA Background: With respect to HAART, culturally relevant exportable interventions are urgently needed to increase adherence, especially among resource-poor, inner city, substance-affected populations.
Methods:
We are conducting an NIMH-funded randomized controlled trial of a peer support intervention to enhance HAART adherence. Participants, mostly African Americans and Puerto Ricans, are outpatients in the Bronx, NY, infected primarily through their own or their partner's injection drug use. Sixty-eight participants were assigned "buddies," patient volunteers who successfully adhere to HAART and receive brief peer support training. The buddies maintain contact with the patients for three months through weekly phone calls and biweekly group meetings, providing experiential knowledge, as well as affirmational, emotional, spiritual, and informational social support. The intervention is designed to target three factors empirically demonstrated to affect adherence: selfefficacy, negative affective states, and knowledge of the medication regimen. We assessed adherence via face-to-face interviews, telephone recalls, and medication event management systems (MEMS) caps at five time periods for this group, as well as for 68 patients in a treatment-as-usual control group. Results: Using data from baseline and immediately post intervention, we will focus on findings regarding (a) initial process evaluation data regarding the feasibility of the peer intervention; (b) cross-sectional analyses of correlates of adherence in order to assess the validity of our proposed model; and (c) outcome data from immediately postintervention.
Conclusions:
We present implications for further research on the design and evaluation of adherence interventions, particularly among populations with few resources.
-Adherence increased through creative community model
Ubaldi-Rosen R, Ferguson A, Van Vladricken K. AIDS Care Group, Chester, PA Recommendations: A call to action is imperative to ensure sustainable treatment options. Ignoring the prospect that incomplete adherence is linked to limited treatment duration as a result of sporadic finances may perpetuate economic devastation that occurs at the household level without evidence of clear benefit. As ART becomes available at no cost to some, government and employer subsidies should be encouraged for those patients paying out-of-pocket to ensure economically sustainable therapy that will maintain fiscal stability at the household level while favoring the best clinical outcomes for all.
-Evaluating the potential use of HIV directly observed therapy (HIV DOT) for incarcerated individuals being released from prison
The, A., Mitty J, Macalino G, Loewenthal H, Sanford S, Flanigan T. The Miriam Hospital, Brown Medical School, Brown University, Providence, RI Background: For HIV-positive individuals being released from prison, adherence to antiretroviral therapy is challenged by factors such as social instability and substance abuse. Given these obstacles, HIV DOT may benefit this special population. The purpose of this study is to evaluate the perceived acceptability of HIV DOT for individuals being released from prison.
Methods: HIV-positive individuals who had a history of incarceration were recruited from a hospital-based clinic. An interviewer-administered questionnaire assessed the following domains: socio-demographic information; history of substance abuse; knowledge of and attitudes toward HIV; adherence to HIV medications in prison and after release; and perceived barriers and facilitators of HIV DOT for individuals leaving prison. Results: Nineteen (13M/6F) HIV-positive patients with a mean age of 45 were interviewed. Sixty-eight percent lived in their own apartment. Eighty-four percent were unemployed, and 84 percent were incarcerated within the past four years. All participants acknowledged the importance of adherence. Identified barriers to HIV DOT include meeting place and frequency of visits. Eighty-four percent did not feel comfortable meeting at a methadone clinic, and 79 percent were not willing to meet five days a week. However, 74 percent viewed outreach workers (ORWs) as a potential source of social support, and 79 percent felt ORWs could serve as a link to their primary care provider (PCP). Eighty-nine percent felt HIV DOT would lead to increased treatment knowledge, and 68 percent believed HIV DOT would enhance adherence. Conclusions: Participants viewed HIV DOT as a means of having social support, maintaining contact with PCPs, getting treatment information, and staying on their medications. However, frequency and location of visits are potential barriers. When developing an observed therapy intervention for this population, support services may need to be integrated into the program. Pilot programs are needed to further assess the acceptability of HIV DOT for individuals being released from prison.
-Observed pegylated interferon dosing, home outreach, and multidisciplinary collaboration to improve access and adherence to hepatitis C virus (HCV) treatment among HIV/HCV coinfected persons
Taylor L, Schwartzapfel B, Champman S, Josiah R, Mitty J. Brown Medical School/The Miriam Hospital, Providence, RI Issues: HIV/HCV coinfection is common, with rates as high as 90 percent in some populations. HCV disease course is accelerated among people with HIV; end-stage liver disease is now a leading cause of illness and death among HIV-positive persons. Combination therapy with pegylated interferon and ribavirin is the standard of care for treatment of HCV, but side effects include flu-like symptoms, anemia, and depression. Prevalence of psychiatric illness and addiction is high among coinfected persons, and many providers are reluctant to prescribe a medication whose efficacy rate decreases with <80 percent adherence. We developed an observed therapy program of intensive home outreach to help coinfected patients through HCV treatment. Description: Patients attend weekly clinic visits where a nurse administers interferon, performs a focused physical exam, assesses side effects and mental health status, and pill packs ribavirin. An outreach worker visits patients at home one to three times weekly to assess their mood and address adherence barriers. Collaboration with a community agency provides psychiatric support.
Lessons learned: Five patients have entered the program. Two are Hispanic, two are white, and one is black; three are women. All have a history of psychiatric illness and addiction. While on therapy, four of five have had their psychiatric medications adjusted based on observations by the outreach team. To date, the mean duration of therapy is 13 weeks (range: nine to 18), with 100 percent of interferon doses observed. Currently three of five patients remain on therapy; one discontinued due to hyperlactatemia which was rapidly addressed as a result of close contact with the outreach team; one chose not to continue treatment.
Recommendations: This intervention promotes adherence and access to HCV therapy among coinfected persons by rapidly identifying and addressing medical and psychiatric issues. Continued research is needed to assess the acceptability and feasibility of observed therapy programs for treatment of HCV in coinfected persons.
-A focus group evaluation of individuals receiving HIV directly observed therapy (HIV DOT)
Loewenthal H, Mitty J, Macalino G, Mock M, MacLeod C, DiCesare R, Flanigan T. The Miriam Hospital, Brown University Medical School, Providence, RI Issues: HIV DOT has been used to enhance adherence for patients receiving highly active antiretroviral therapy with substance abuse and other psychosocial issues. In-depth evaluations of individuals receiving HIV DOT are needed to better understand how to refine and utilize this intervention. Description: A focus group was conducted with a group of individuals who were enrolled in a pilot observed therapy program. Questions were solicited in the following domains: HIV knowledge and attitudes, privacy/confidentiality, number of weekly visits, visit location, tapering of visits, outreach worker (ORW)/nursing support, side effects, and pharmacy issues. Future focus groups are planned. Lessons learned: Four patients participated in the group, with an average duration on HIV DOT of five months. All patients either had a history of substance abuse or are currently using; two were male, one Cape Verde, one Native American, and two African American. Overall, HIV DOT is a well-accepted intervention.
Three key aspects emerged in frequency and intensity. 1) ORW Role: All patients agreed that the ORW provided social support, was a constant and caring presence in their life, and served as a liaison to medical care. 2) ORW Visits: Two patients agreed that starting on five days was optimal, as weekends were important for social interaction, and two patients felt it was important to start on seven days as it provided a foundation for the daily practice of taking medication. All felt that the ORW being on time for their visits was essential. 3) Visit Site: All agreed that home visits provided the highest degree of privacy. None were interested in alternative sites. Recommendations: HIV DOT is an acceptable intervention among this population. The role of the ORW in providing continuity, stability, and enhancing access to patient care is a pivotal element of the intervention. Thus, developing a trusting relationship with the ORW appears to be a key component in the success of observed therapy programs.
-Addressing providers' adherence related knowledge, skills and attitudes
Jordan D, Mackey-Padilla J, Merrill C. Inova Juniper Program, Fairfax, VA
Since the patient-provider relationship plays a key role in adherence to HAART, this intervention focused on enhancing providers' awareness of the role adherence plays in the success of HAART, and strengthening their ability to support adherence in their patients. A multi-component training program focused on three main areas: understanding current treatment strategies; fostering an empathic response to adherence challenges; and building skills that enhance the provider's ability to support adherence. A variety of experiential training strategies were employed, including role-plays, exploration of values and beliefs, and measuring provider's adherence to a mock HAART regimen. Consumer input played a key role in each training strategy. Providers participating in the training included physician's assistants, RNs, educators, and peer advocates. HIV-related knowledge and experience ranged from a minimal to very high level. Three sessions have been held for 17 providers as part of the ongoing clinical training program of the No. VA Local Performance Site of the PA MA AETC. From responses available to date, >95 percent reported the training met its objectives as well as participants' personal training needs. Providers reported that they anticipated this training would enhance their effectiveness in supporting adherence in their patients. Several providers reported that the strategies learned were applicable to patients with other chronic illnesses and would be incorporated into their general practice. Adherence levels to the mock regimen ranged from 0 to 100 percent with under-reporting at the lower levels. Future directions include extending the training to a larger number of participants in order to validate and further quantify the results. Identifying most effective training strategies for varying levels of HIV knowledge and experience is another future goal. In addition, six-month follow-up surveys are planned to assess how providers have integrated strategies into their clinical practice.
-Medication adherence exercise: An active learning activity for HIV clinicians in a clinical preceptorship
Loeb-Guth D, Cunningham S. Delta Region AIDS Education and Training Center, New Orleans, LA Traditionally, training programs for HIV clinicians teach HIV pharmacology, including regimens and side effects in a didactic format with little personal attitudinal change or active participation. An experiential activity was devised to increase participants' understanding of the complex issues surrounding HAART medication adherence. Candies of various sizes, shapes, and colors were labeled to simulate medications. Trainers gave each participant an empty pillbox and a prescription, and instructed them to fill their pillboxes with the appropriate mock medications for the duration of the three-day training program. Dosing regimens assigned were from as few as one pill bid, to as many as 26 pills per day. Thirty-one participants returned training evaluations.
Using a five-point scale, participants rated the effectiveness of the training activities. Compared to other preceptorship activities (Powerpoint presentations, skill-building workshop, and clinical rotation), the experiential medication adherence exercise was rated as effective (86.6 percent agreed), but less so than the Powerpoint presentations (96.8 percent). On a separate medication administration record, participants described their regimens, side effects, and personal experiences. The following barriers to adherence were noted among participants: 1) medications required establishing new routines and changes in routines caused nonadherence; 2) evening doses were hard to remember; 3) pills were difficult to swallow; and 4) food restrictions were difficult. This activity allowed participants to experience medication regimens, and to discuss the experience among professional peers. Some participants reported not enjoying the activity (10 percent). However, their opinion had to do more with the challenge of taking medication than with the exercise itself. Participants reported many of the same attitudes that are expressed by patients on difficult medication regimens. Three-month follow-up evaluation will examine the perceived effectiveness of the activity, as well as recall of the medications and their effects. Future training programs should increase the use of active participatory activities in clinical training.
-Teaching a stages of change model to a multidisciplinary audience as a clinical tool to maximize medication adherence
Blevins J, Weaver B. Emory University School of Medicine, Atlanta, GA
